Abstract

COVID-19 is a highly infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Although the exact diagnosis, clinical and treatment features for SARS-CoV-2 infection have not been determined yet, the accumulation of knowledge is increasing day by day. However, there is still insufficient information about the cellular and molecular regulation of SARS-CoV-2. The development of miRNA targeting anti-viral therapies in the literature has attracted great interest and have been considered as promising biomarker(s) and novel target(s) for therapeutic approaches.

Highlights

  • Coronaviruses are a group of single stranded RNA viruses with viral spike proteins on their surface [1]

  • This review summarizes potential mRNA-inhibiting RNAs (miRNAs) that can be targeted for the further therapies of SARS-CoV-2 infections

  • A general review of current studies concerning the function of miRNAs in SARS-CoV-2 infection, and available therapeutic prospects to mitigate the burden of viral infections were presented

Read more

Summary

Introduction

Coronaviruses are a group of single stranded RNA viruses (ssRNA) with viral spike proteins on their surface [1]. The E protein is Citation: SEVGIN O, SEVGIN K (2021) Systematic Review of microRNAs in the SARS-CoV-2 Infection: Are microRNAs Potential Therapy for COVID-19?. Most of the SARS-CoV-2 and miRNA related studies have been made in silico analysis, there are some studies that present potential miRNA gene regulations experimentally.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call